- Global Landscape and Thematic Evolution of Selective GLP ‐1 Receptor Agonists and GLP ‐1–Based Multi‐Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis
Endocrinology Diabetes & Metabolism · 2026
- Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed care
Journal of Managed Care & Specialty Pharmacy · 2026
- Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study
PLoS ONE · 2026
- Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review
Endocrinology Diabetes & Metabolism · 2026
- Comparative Cardiovascular Outcomes of GLP ‐1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta‐Analysis
Endocrinology Diabetes & Metabolism · 2026
- Benefits of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide-1 receptor agonists in older patients with type 2 diabetes
Diabetes and Vascular Disease Research · 2026
- Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2026
- Glucagon-like peptide-1 receptor agonists and the risk of Parkinson’s disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data
Frontiers in Endocrinology · 2026
- Glucagon-like peptide-1 receptor agonist-based regimens compared with metformin-based regimens for preventing cardiovascular disease in adults with type 2 diabetes mellitus
Cochrane Database of Systematic Reviews · 2026
- Polish healthcare professionals’ perceptions of GLP-1 receptor agonists in cardiometabolic risk reduction: a cross-sectional online survey in Poland
Frontiers in Endocrinology · 2026
- Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis
BMJ Open · 2026
- Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery
JAMA Network Open · 2026
- Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure
Diabetes and Vascular Disease Research · 2026
- Comparative Efficacy and Safety of Tirzepatide in Asian and Non‐Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta‐Analysis
Endocrinology Diabetes & Metabolism · 2026
- Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists
Cardiovascular Toxicology · 2026
- Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review
BMJ Open Diabetes Research & Care · 2026
- Consenso multidisciplinario chileno sobre el uso de agonistas de GLP-1: Recomendaciones basadas en metodología GRADE
Revista médica de Chile · 2026
- Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence
Cureus · 2026
- Glucagon‐Like Peptide‐1 Receptor Agonist Use in Obese Patients Is Associated With Decreased Risk of Revision and Retears After Arthroscopic Rotator Cuff Repair
Arthroscopy The Journal of Arthroscopic and Related Surgery · 2026
- Effects of glucagon-like peptide-1 receptor agonists on anthropometric and adiposity measures in patients with antipsychotic-induced weight gain: A systematic review and meta-analysis
Journal of Psychopharmacology · 2026
- Glucagon-Like Peptide-1 Receptor Agonists in Cardiovascular Disease: Redefining Therapy Through Cardiometabolic Substrate Modification
Cardiology in Review · 2026
- Combining Sodium–Glucose Co‐Transporter‐2 Inhibitor Plus Glucagon‐Like Peptide‐1 Receptor Agonist for Glucose‐Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real‐World Clinical Practice ( <scp>CombiKid</scp> Study)
Diabetes Obesity and Metabolism · 2026
- Efficacy of glucagon-like-peptide-1 agonists for weight loss in adults with CHD
Cardiology in the Young · 2026
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Following Orthopedic Shoulder Surgery: A Comparative Analysis
Cureus · 2026
- Glucagon-Like Peptide-1 Receptor Agonists Across the Heart Failure Spectrum: A Systematic Review and Meta-Analysis
Cureus · 2026
- The Efficacy of Glucagon-like Peptide-1 Based Therapies in Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 2026
- Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review
Cardiovascular Diabetology · 2026
- Glucagon-Like Peptide-1 Receptor Agonist Use and Postoperative Outcomes After Distal Radius Fracture Fixation in Adults With Type 2 Diabetes
Hand · 2026
- The Association Between Glucagon-like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Thoracic Aortic Aneurysm
Diagnostics · 2026
- GLP-1 receptor agonist use and aspiration pneumonia risk following endovascular thrombectomy
Journal of NeuroInterventional Surgery · 2026
- 2200-P: Real-World Effectiveness of Novel Antidiabetic Medications on Cardiovascular Outcomes among Medicare Beneficiaries by Race
Diabetes · 2026
- 2201-P: Effectiveness and Safety of SGLT2i, GLP-1RA, and DPP-4i in Adults with T2D at Low-to-Moderate Cardiovascular Risk: An International Cohort Study
Diabetes · 2026
- 2069-P: Risk of Suicidal Ideation and Behaviors, Depression, and Anxiety with GLP-1 Receptor Agonist Use in Children and Adolescents: A Target Trial Emulation Study
Diabetes · 2026
- Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care
Diabetology International · 2026
- Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients With Obesity and Without Type 2 Diabetes
Diabetes Obesity and Metabolism · 2026
- GLP-1 receptor agonists: from glycaemic control to cardio-reno-metabolic disease modification
European Heart Journal - Quality of Care and Clinical Outcomes · 2026
- Association Between Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obesity
Drug Design Development and Therapy · 2026
- GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW OF THEIR ROLE ACROSS MULTIPLE ORGAN SYSTEMS BEYOND WEIGHT MANAGEMENT
2026
- GLP-1 receptor agonists and post-endovascular thrombectomy outcomes in acute ischemic stroke: a multicenter propensity score matched analysis
Journal of Clinical Neuroscience · 2026
- Perioperative glucagon-like peptide-1 receptor agonist use and surgical outcomes in patients with morbid obesity (BMI > 35) undergoing robotic urologic surgery: A propensity score-matched analysis
Journal of Robotic Surgery · 2026
- Beyond cardio-renal outcomes with GLP-1RA and SGLT2i in anthracycline-treated diabetic women with breast cancer: A propensity score–matched analysis from Global Federated Health Research Network.
Journal of Clinical Oncology · 2026
- Racial and Ethnic Disparities in GLP-1 Prescriptions Among Veterans with Obesity Across Direct and Community Care Settings
Health Affairs Scholar · 2026
- Glucagon-like Peptide-1 Receptor Agonists in Rheumatoid Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, and Cardioprotective Effects
Journal of Personalized Medicine · 2026
- Lifestyle First and Lifestyle Always, Does Not Mean Lifestyle Only: Reimagining Cardiometabolic Care in the Era of GLP-1 Receptor Agonists
American Journal of Lifestyle Medicine · 2026
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Mediating Myocardial Resilience in Cardiac Surgery
Cardiology in Review · 2026
- Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World Analysis
Neurology International · 2026
- Body Composition Changes in Patients on GLP-1 Receptor Agonists Undergoing an Intensive Cardiac Rehabilitation Program
European Journal of Preventive Cardiology · 2026
- Pharmacovigilance Assessment of Thrombotic Adverse Events Linked to GLP-1 Receptor Agonists: Analysis of FAERS Reports from 2020–2025
Current Drug Safety · 2026
- Preoperative Weight Loss Intervention With Glucagon-Like Peptides 1 Receptor Agonists Is Associated With Lower Complication Rates Following Primary Total Knee Arthroplasty Than Preoperative Bariatric Surgery
Arthroplasty Today · 2026
- The Efficacy of Glucagon‐like Peptide‐1 Receptor Agonists on DifferentCognitive Domains: A Meta-analysis of Randomized Controlled Trials
Current Neuropharmacology · 2026